Negative Impact of Pulmonary Hypertension in TAVR

Courtesy of Dr. Carlos Fava.

The presence of pulmonary hypertension (PH) is frequent in severe aortic stenosis. This can be classified in: isolated pre-capillary PH, isolated post-capillary PH, and combined post-capillary and pre-capillary PH. 

At present, little research has looked into the disease from this perspective. 

The study looked at 1400 patients and divided them into 4 groups: 658 had no PH (mPAP< 25 mmHg), 139 had isolated pre-capillary PH (mPAP ≥25 mmHg and capillary wedge pressure ≤15 mmHg), 534 had isolated post-capillary PH (mPAP≥ 25 mmHg and capillary wedge pressure >15 mmHg), and 69 combined post-capillary and pre-capillary PH (mPAP≥ 25 mmHg, capillary wedge pressure >15 mmHg and pulmonary diastolic gradient ≥7 mmHg).

Mean age was 81 and 46% were men. The 3 groups with PH had more prevalence of AS and more comorbidities. 


Read also: Pulmonary Hypertension: No Reason for TAVR Contraindication.


Procedural success was 94.9%, with no differences in leaks, stroke, bleeding, vascular complication and kidney failure. In hospital mortality was higher in patients presenting isolated pre-capillary and isolated post-capillary PH.

12 month and 4 year follow ups showed lower mortality in patients with no PH vs those with PH [at one year 13.8% vs 23.4% (p<0.001) and at 4 years 37.2 vs. 51.5% (p<0.001)].

At one year, mortality was nearly twice as high patients with isolated pre-capillary HP, and patients with isolated post-capillary PH experienced a 1.5 mortality increase vs. those with no PH. There were no differences in survival in patients with PH.  

In 25% of patients with isolated pre-capillary PH and isolated post-capillary PH the process was reversible, which was associated with better survival. This did not happen in patients with combined post-capillary and pre-capillary PH


Read also: TCT 2018 | PADN-5: Pulmonary Artery Denervation in Pre- and Post-Capillary Pulmonary Hypertension.


Functional class improved at follow up in all groups. Mortality predictors at one year were age, glomerular filtration, COPD, stroke, cardiac index, PH, isolated pre-capillary PH, and isolated post-capillary PH. 

Conclusion

Patients with isolated pre-capillary and isolated post-capillary PH showed higher mortality after TAVR compared to patients with no PH. Reversible PH did no show benefits except in patients with isolated pre-capillary PH.

Hemodynamic stratification of PH helps predict risk and AS patient response after TAVR. 

Courtesy of Dr. Carlos Fava.

Original Title: Impact of Pulmonary Hypertension Hemodynamic Status on Long-Term Outcome After Transcatheter Aortic Valve Replacement.

Reference: Jury Schewel, et al. J Am Coll Cardiol Intv 2019;12:2155–68.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...

TAVR in Young Low-Risk Patients

Transcatheter aortic valve replacement (TAVR) has established itself as an effective strategy for the treatment of severe aortic stenosis across different risk groups. While previous...

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series. This arrhythmia has been associated to higher...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...